[1]
Corren, J. , Szefler, S.J. , Sher, E. , Korenblat, P. , Soong, W. , Hanania, N.A. , Berman, G. , Brusselle, G. , Zitnik, R. , Natalie, C.R. , Siu, K. , Wu, W.-S. , Qiao, M. , Lio, P. and Armstrong, A.W. 2025. Post-Hoc Analyses Support Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Uncontrolled Eosinophilic Asthma and Prior Exacerbations. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s524. DOI:https://doi.org/10.25251/skin.9.supp.524.